Cigna Group (NYSE:CI) Updates FY 2026 Earnings Guidance

Cigna Group (NYSE:CI) issued an update on its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 30.450- for the period, compared to the consensus EPS estimate of 30.400. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and dropped their target price for the stock from $303.00 to $302.00 in a research note on Wednesday, May 20th. Jefferies Financial Group dropped their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research note on Monday, April 20th. Piper Sandler decreased their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. Finally, Barclays upped their price target on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $341.60.

Cigna Group Trading Down 2.9%

Shares of Cigna Group stock opened at $279.27 on Friday. The company has a current ratio of 0.76, a quick ratio of 0.73 and a debt-to-equity ratio of 0.68. The firm’s 50-day moving average price is $286.62 and its 200 day moving average price is $281.10. The firm has a market capitalization of $73.88 billion, a PE ratio of 11.55, a P/E/G ratio of 1.11 and a beta of 0.29. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same period last year, the business earned $7.20 earnings per share. Cigna Group’s revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, sell-side analysts predict that Cigna Group will post 30.4 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s payout ratio is 26.45%.

Insider Buying and Selling at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Key Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported adjusted second-quarter earnings of $7.78 per share, above the roughly $7.60 consensus estimate, while revenue rose 7% year over year to approximately $71.7 billion. Cigna Healthcare revenue increased 9%, and Evernorth Health Services revenue grew 6%. Cigna Q2 results and outlook
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.45 per share, implying approximately 10% earnings growth, supported by strength across the healthcare and pharmacy-benefit businesses. Cigna raises annual profit forecast
• Positive Sentiment: Analyst sentiment remains constructive: Barclays raised its price target from $304 to $310 while retaining an “equal weight” rating. A separate analysis highlighted CI’s discounted valuation, ongoing share repurchases, strong cash generation, and $1.56-per-share dividend. Cigna valuation analysis
• Neutral Sentiment: The earnings beat was accompanied by revenue that was slightly below some analyst estimates, and Barclays’ “equal weight” stance suggests the improved outlook may already be partly reflected in the stock.
• Negative Sentiment: Cigna expects lower growth in prescriptions for popular GLP-1 drugs. Because these treatments are a significant growth area for pharmacy services, slower utilization could temper future revenue and profit expansion. Cigna GLP-1 prescription outlook
• Negative Sentiment: Elevated medical costs and higher pharmacy expenses remain industrywide risks. Those pressures may explain why investors initially treated the guidance increase cautiously despite Cigna’s higher profit and broad-based operating growth.

Institutional Trading of Cigna Group

A number of hedge funds have recently added to or reduced their stakes in the stock. Wilkerson Advisory Group LLC acquired a new position in shares of Cigna Group in the fourth quarter valued at approximately $25,000. Prosperity Bancshares Inc purchased a new position in Cigna Group in the 4th quarter valued at $29,000. Kemnay Advisory Services Inc. acquired a new position in Cigna Group in the 4th quarter valued at $29,000. Measured Wealth Private Client Group LLC purchased a new position in Cigna Group during the 3rd quarter worth $56,000. Finally, Johnson Financial Group Inc. lifted its stake in shares of Cigna Group by 445.9% in the 3rd quarter. Johnson Financial Group Inc. now owns 202 shares of the health services provider’s stock worth $58,000 after acquiring an additional 165 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.